Abstract:Removing excessively produced cytokines is of paramount significance in blood purification therapy for hypercytokinemia-associated diseases. In this study, we devised a conduit that is modified with nanobodies (Nb) and incorporates static mixers (Nb-SMC) to eliminate surplus cytokines from the bloodstream. The low-pressure-drop (LPD) static mixer, with each unit featuring two 90°-crossed blades, was strategically arranged in a tessellated pattern on the inner wall of the conduit to induce turbulent mixing effects during the flow of blood. This arrangement enhances mass transfer and molecular diffusion, thereby assisting in the identification and elimination of cytokines. By utilizing computational fluid dynamics (CFD) studies, the Nb-SMC was rationally designed and prepared, ensuring an optimal interval between two mixer units (H/G = 2.5). The resulting Nb-SMC exhibited a remarkable selective clearance of IL-17A, reaching up to 85 %. Additionally, the process of Nb immobilization could be adjusted to achieve the simultaneous removal of multiple cytokines from the bloodstream. Notably, our Nb-SMC displayed good blood compatibility without potential adverse effects on the composition of human blood. As the sole documented static mixer-integrated conduit capable of selectively eliminating cytokines at their physiological concentrations, it holds promise in the clinical potential for hypercytokinemia in high-risk patients. STATEMENT OF SIGNIFICANCE: High-efficient cytokines removal in critical care still remains a challenge. The conduit technique we proposed here is a brand-new strategy for cytokines removal in blood purification therapy. On the one hand, nanobody endows the conduit with specific recognition of cytokine, on the other hand, the build-in static mixer enhances the diffusion of antigenic cytokine to the ligand. The combination of these two has jointly achieved the efficient and specific removal of cytokine. This innovative material is the only reported artificial biomaterial capable of selectively eliminating multiple cytokines under conditions close to clinical practice. It has the potential to improve outcomes for patients with hypercytokinemia and reduce the risk of adverse events associated with current treatment modalities.

Nanobody-Based High-Performance Immunosorbent for Selective Beta 2-Microglobulin Purification from Blood.

Development of a Hybrid Biomimetic Ligand with High Selectivity and Mild Elution for Antibody Purification

A Novel Dextran-Grafted Tetrapeptide Resin for Antibody Purification

Development of a disposable micro-capillary film grafted with peptide ligands for immunoadsorption.

Binary Adsorption Processes of Albumin and Immunoglobulin on Hydrophobic Charge-Induction Resins

Experimental and in Silico Studies on Three Hydrophobic Charge-Induction Adsorbents for Porcine Immunoglobulin Purification

Mixed-Mode Expanded-Bed Adsorption for Human Serum Albumin Separation

Design of Beta-2 Microglobulin Adsorbent Protein Nanoparticles

Nanobody-loaded immunosorbent for highly-specific removal of interleukin-17A from blood

Biparatopic Nanobody-Based Immunosorbent for the Highly Selective Elimination of Tumor Necrosis Factor-α

Immunogenicity Risk Profile of Nanobodies

Specific recognition of bovine serum albumin using superparamagnetic molecularly imprinted nanomaterials prepared by two-stage core-shell sol-gel polymerization

Nanobody-functionalized conduit with built-in static mixer for specific elimination of cytokines in hemoperfusion

Lifting the Veil: Characteristics, Clinical Significance, and Application of β-2-Microglobulin as Biomarkers and Its Detection with Biosensors

A novel recyclable hemoperfusion adsorbent based on TiO2 nanotube arrays for the selective removal of β2-microglobulin

Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

A non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluids

Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli

Large-pore, silica particles with antibody-like, biorecognition sites for efficient protein separation

Screening and validation of an alkaline-tolerant biomimetic affinity chromatography A5-87 resin for purification of discarded bovine serum Immunoglobulin G

Non-immunoglobin scaffold binders as efficient affinity ligands for purification of broad-spectrum serum albumins